Skip to main content

Diagnostic options · UAE

Genetic Panels tests in Dubai & UAE

Compare available Genetic Panels tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

15

Listed price range

2,500.00–5,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Panels test prices

Showing 1–15 of 15 matching tests.

Genetic Panels diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3666
Amyotrophic Lateral Sclerosis (ALS) Panel Genetic Test

This genetic test identifies pathogenic variants in multiple genes associated with Amyotrophic Lateral Sclerosis (ALS). It helps confirm a genetic diagnosis and provides informatio...

Peripheral whole blood (3-5 mL in EDTA tube) or dried blood spot (FTA card) 3-4 Weeks 3,000.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in ALS-associated genes (e.g., SOD1, C9orf72, TARDBP, FUS)", "Genetic predisposition to ALS"]
Parameters
[]
Preparation
[]
Indications
["Suspected diagnosis of ALS", "Family history of ALS", "Differential diagnosis of motor neuron disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101234-0 ICD-10: G12.21
Clinical summary
This genetic test identifies pathogenic variants in multiple genes associated with Amyotrophic Lateral Sclerosis (ALS). It helps confirm a genetic diagnosis and provides information for prognosis and genetic counseling.
TEST-1839
Autism Gene Panel Test

This test identifies pathogenic variants in over 200 genes associated with autism spectrum disorder using next-generation sequencing.

['Peripheral whole blood', 'Amniotic fluid', 'Chorionic villi'] 4–6 weeks (from sample receipt) 3,000.00 AED
View
View test specifications and preparation
What it measures
["Clinically significant variants in genes associated with autism spectrum disorder", "Analytical sensitivity", "Diagnostic sensitivity"]
Parameters
[]
Preparation
["No specific fasting required for blood samples", "Physician's prescription required for blood collection (exceptions apply)", "Obstetrician-specialist referral mandatory for prenatal samples"]
Indications
["Individuals with features of autism spectrum disorder", "Family planning evaluations when a genetic cause is suspected", "Strong family history of autism spectrum disorder"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 98173-3 ICD-10: ['Z13.41', 'F84.0', 'Z84.8']
Clinical summary
This test identifies pathogenic variants in over 200 genes associated with autism spectrum disorder using next-generation sequencing.
TEST-1757
Bone Marrow Failure Syndrome Genetic Panel Test

This test identifies genetic mutations associated with inherited bone marrow failure syndromes using next-generation sequencing.

Peripheral whole blood (2× EDTA tubes) 4–6 weeks 4,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in genes linked to inherited bone marrow failure (e.g., FANCA, DKC1, TERT, SBDS)", "Genetic predisposition to bone marrow failure syndromes"]
Parameters
[]
Preparation
["No fasting or special preparation is required", "Phlebotomist will collect a peripheral blood sample"]
Indications
["Diagnosis of suspected inherited bone marrow failure syndromes", "Prognosis assessment", "Family planning and genetic counselling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81319-8 ICD-10: D61.9
Clinical summary
This test identifies genetic mutations associated with inherited bone marrow failure syndromes using next-generation sequencing.
TEST-1704
Common Neurological/Neuromuscular Diseases Gene Panel Test

This test identifies pathogenic DNA variants in over 200 genes associated with inherited neuromuscular conditions.

Peripheral blood (EDTA) – standard; amniotic fluid / chorionic villi available under specialist guidance 4–6 weeks 4,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic DNA variants", "Inherited mutations"]
Parameters
[]
Preparation
["A valid physician’s prescription is required, except for specific cases.", "No fasting is needed for peripheral blood collection.", "Inform the phlebotomist if taking anticoagulants."]
Indications
["Suspected inherited neurological disorder", "Suspected inherited neuromuscular disorder", "Family history of relevant genetic conditions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95156-4 ICD-10: G71.0
Clinical summary
This test identifies pathogenic DNA variants in over 200 genes associated with inherited neuromuscular conditions.
TEST-25
Comprehensive Ophthalmic Genetic Disorder Panel Test

This test evaluates over 500 genes associated with inherited eye disorders using Next Generation Sequencing.

Whole Blood (EDTA) or FTA Card Finger-Prick 21 Working Days 3,000.00 AED
View
View test specifications and preparation
What it measures
["Genetic variants in over 500 genes", "Deletions and duplications (CNV detection)"]
Parameters
[]
Preparation
[]
Indications
["Patients with suspected inherited retinal diseases", "Patients with unexplained visual impairment", "Family history of inherited eye conditions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81303-8 ICD-10: H35.5
Clinical summary
This test evaluates over 500 genes associated with inherited eye disorders using Next Generation Sequencing.
TEST-3686
Dementia Panel Genetic Test

This test evaluates for pathogenic variants in over 50 genes linked to hereditary dementia.

Whole Blood (Peripheral) 3 to 4 weeks 3,000.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in dementia-associated genes", "Genetic predisposition to neurodegenerative disorders"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any current medications"]
Indications
["Early risk stratification for dementia", "Personalised care planning", "Identification of hereditary dementia risk"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101349-1 ICD-10: Z13.858
Clinical summary
This test evaluates for pathogenic variants in over 50 genes linked to hereditary dementia.
TEST-3110
Dysmorphology Panel Genetic Test

This test evaluates over 300 genes associated with dysmorphic syndromes using Next-Generation Sequencing (NGS). It detects SNVs, indels, and CNVs to identify the genetic basis of c...

Peripheral whole blood 3–4 Weeks 3,000.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "No special preparation required"]
Indications
["Individuals with clinical features suggestive of a genetic syndrome", "Undiagnosed rare diseases", "Complex congenital anomalies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94231-1 ICD-10: Q87.89
Clinical summary
This test evaluates over 300 genes associated with dysmorphic syndromes using Next-Generation Sequencing (NGS). It detects SNVs, indels, and CNVs to identify the genetic basis of congenital anomalies.
TEST-1637
Dystonia Gene Panel Test

This test identifies pathogenic mutations in over 100 genes associated with inherited dystonia syndromes using Next-Generation Sequencing.

Peripheral blood, amniotic fluid, chorionic villi 4–6 weeks 4,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants (SNVs, indels, CNVs) in dystonia-associated genes", "Genetic predisposition to dystonia"]
Parameters
[]
Preparation
["No fasting required for blood samples", "Specific instructions provided by obstetrician for prenatal samples"]
Indications
["Diagnosis of primary dystonia", "Diagnosis of dystonia-plus syndromes", "Diagnosis of paroxysmal dystonias", "Family history of dystonia", "Exclusion of other neurological disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: G24.9
Clinical summary
This test identifies pathogenic mutations in over 100 genes associated with inherited dystonia syndromes using Next-Generation Sequencing.
TEST-3709
Dystonia Panel Genetic Test

This test evaluates for pathogenic variants in genes known to be associated with primary and hereditary dystonia syndromes.

Whole Blood (Peripheral) or FTA Card (Dried Blood Spot) 21–28 business days from sample receipt 3,000.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "Continue all prescribed medications unless advised otherwise by your physician"]
Indications
["Diagnosis of primary or hereditary dystonia", "Family screening for dystonia-associated genes", "Prognosis and treatment guidance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81314-9 ICD-10: G24.9
Clinical summary
This test evaluates for pathogenic variants in genes known to be associated with primary and hereditary dystonia syndromes.
TEST-1320
Genodermatoses Exome Sequencing Panel Test

This test analyzes the exome (protein-coding regions) of genes associated with inherited skin disorders.

Peripheral Whole Blood 30 Working Days 5,000.00 AED
View
View test specifications and preparation
What it measures
["Protein-coding regions of genes linked to inherited skin disorders", "Rare and novel genetic variants"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of suspected hereditary dermatological conditions", "Identification of rare and novel variants", "Familial risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94474-8 ICD-10: Z13.89
Clinical summary
This test analyzes the exome (protein-coding regions) of genes associated with inherited skin disorders.
TEST-1522
Hereditary Spastic Paraplegia Gene Panel Test

This test evaluates known genes associated with hereditary spastic paraplegia (HSP) using next-generation sequencing to identify pathogenic variants.

Peripheral blood (2 × EDTA tubes), Amniotic fluid, Chorionic villi 4 to 6 weeks 4,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in HSP-associated genes", "Inheritance patterns (autosomal dominant, recessive, X-linked)"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of suspected HSP", "Screening of at-risk relatives", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 103208-0 ICD-10: G11.4
Clinical summary
This test evaluates known genes associated with hereditary spastic paraplegia (HSP) using next-generation sequencing to identify pathogenic variants.
TEST-1434
Leigh Syndrome & Mitochondrial Encephalopathy Gene Panel Test

This test evaluates for pathogenic variants in genes associated with Leigh syndrome and mitochondrial encephalopathy using a targeted NGS panel.

Amniotic fluid, Chorionic villus sampling (CVS), Peripheral blood 4–6 weeks 4,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in nuclear genes associated with Leigh syndrome", "Pathogenic variants in mitochondrial DNA associated with mitochondrial encephalopathy"]
Parameters
[]
Preparation
["No specific fasting required for blood samples.", "Inform the lab of any recent blood transfusions (within 2 weeks)."]
Indications
["Suspected diagnosis of Leigh syndrome", "Suspected diagnosis of mitochondrial encephalopathy", "Carrier screening for at-risk families", "Prenatal diagnosis in high-risk pregnancies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94050-9 ICD-10: G31.82, G31.81
Clinical summary
This test evaluates for pathogenic variants in genes associated with Leigh syndrome and mitochondrial encephalopathy using a targeted NGS panel.
TEST-435
Limb-Girdle Muscular Dystrophy (LGMD) NGS Panel Test

This test evaluates for genetic mutations in genes associated with Limb-Girdle Muscular Dystrophy (LGMD). It identifies pathogenic variants to confirm diagnosis and guide managemen...

Peripheral whole blood 14–21 working days 2,500.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in LGMD-associated genes", "Copy number variants (CNVs) in LGMD-associated genes"]
Parameters
[]
Preparation
["No fasting required", "List all current medications", "Share relevant family history"]
Indications
["Patients with clinical suspicion of Limb-Girdle Muscular Dystrophy", "Family history of LGMD", "Need for precise genetic diagnosis for management and counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81262-6 ICD-10: G71.0
Clinical summary
This test evaluates for genetic mutations in genes associated with Limb-Girdle Muscular Dystrophy (LGMD). It identifies pathogenic variants to confirm diagnosis and guide management.
TEST-1349
Microcephaly Gene Panel Test

This test evaluates multiple genes known to be associated with microcephaly by sequencing the patient's DNA.

Peripheral Whole Blood 4 to 6 weeks 4,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in microcephaly-associated genes", "Copy number variations (CNVs) in relevant genes"]
Parameters
[]
Preparation
["No specific fasting required", "Inform the phlebotomist of any medications being taken"]
Indications
["Individuals with microcephaly", "Children or adults with unexplained developmental delay and reduced head circumference", "Family history of microcephaly or related genetic disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81304-2 ICD-10: Q02
Clinical summary
This test evaluates multiple genes known to be associated with microcephaly by sequencing the patient's DNA.
TEST-4447
Pulmonary Panel Genetic Test

This test evaluates over 100 genes associated with hereditary cardiopulmonary disorders using Next-Generation Sequencing (NGS). It aims to provide a definitive molecular diagnosis...

Peripheral Whole Blood / Extracted DNA / FTA Card 3–4 weeks 3,000.00 AED
View
View test specifications and preparation
What it measures
["Genetic variants in >100 cardiopulmonary genes", "Single Nucleotide Polymorphisms (SNPs)", "Insertions/Deletions (Indels)"]
Parameters
[]
Preparation
["No specific fasting required", "Do NOT discontinue prescribed medications unless advised by your doctor"]
Indications
["Suspected hereditary pulmonary hypertension", "Suspected cystic fibrosis", "Suspected primary ciliary dyskinesia", "Familial interstitial lung disease", "Unexplained chronic respiratory symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94303-1 ICD-10: Z13.83
Clinical summary
This test evaluates over 100 genes associated with hereditary cardiopulmonary disorders using Next-Generation Sequencing (NGS). It aims to provide a definitive molecular diagnosis for conditions like pulmonary hypertension and cystic fibrosis.

Category overview

Genetic Panels: overview

When clinical symptoms are ambiguous and point to multiple potential conditions, having access to a specialized suite of targeted diagnostics ensures absolute certainty. As an advanced offering in our Molecular Genetics department, our customizable Genetic Panels allow physicians to deeply target specific biological pathways—from metabolic functions to neurodevelopment—based on your unique presentation. By leveraging state-of-the-art diagnostic technology, this highly adaptable screening provides the exact clarity required to diagnose complex inherited disorders, safely guiding highly tailored medical interventions and specialized clinical oversight. Trusted by specialists across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and incredibly efficient reporting. Take an empowered step in your healthcare journey—book your genetic panels testing in UAE, arrange a comfortable clinical sample collection, or reach out to our dedicated medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.